Changes to its peptidoglycan-remodeling enzyme repertoire modulate β-lactam resistance in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 3078-3084

  Cavallari, Joseph F ^a   Lamers, Ryan P ^a   Scheurwater, Edie M ^a   Matos, Andrea L ^a   Burrows, Lori L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAM; BETA LACTAMASE AMPC; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GLYCOSYLTRANSFERASE; IMIPENEM; LYTIC TRANSGLYCOSYLASE; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 4; PEPTIDOGLYCAN; PIPERACILLIN; PROTEIN MLTB; PROTEIN SLTB1; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; GENOTYPE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; WILD TYPE;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; GLYCOSYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; PENICILLIN-BINDING PROTEINS; PEPTIDOGLYCAN; PSEUDOMONAS AERUGINOSA;

EID: 84879005144     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00268-13     Document Type: Article

References (42)

1. Blanc DS, Francioli P, Zanetti G. 2007. Molecular epidemiology of Pseudomonas aeruginosa in the intensive care units-a review. Open Microbiol. J. 1:8-11.
2. Giamarellou H, Poulakou G. 2009. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 69:1879-1901.
3. Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74:417-433.
4. Mark BL, Vocadlo DJ, Oliver A. 2011. Providing beta-lactams a helping hand: targeting the AmpC beta-lactamase induction pathway. Future Microbiol. 6:1415-1427.
5. Vollmer W, Joris B, Charlier P, Foster S. 2008. Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol. Rev. 32:259-286. (Pubitemid 351257818)
6. Johnson JW, Fisher JF, Mobashery S. 2013. Bacterial cell-wall recycling. Ann. N. Y. Acad. Sci. 1277:54-75.
7. Lee M, Hesek D, Llarrull LI, Lastochkin E, Pi H, Boggess B, Mobashery S. 2013. Reactions of all Escherichia coli lytic transglycosylases with bacterial cell wall. J. Am. Chem. Soc. 135:3311-3314.
8. Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT. 1994. Bacterial cell wall recycling provides cytosolic muropeptides as effectors for betalactamase induction. EMBO J. 13:4684-4694. (Pubitemid 24310220)
9. Moya B, Dotsch A, Juan C, Blazquez J, Zamorano L, Haussler S, Oliver A. 2009. Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein. PLoS Pathog. 5:e1000353. doi:10.1371/journal.ppat.1000353.
10. Moyá B, Beceiro A, Cabot G, Juan C, Zamorano L, Alberti S, Oliver A. 2012. Pan-beta-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities. Antimicrob. Agents Chemother. 56:4771-4778.
11. Tayler AE, Ayala JA, Niumsup P, Westphal K, Baker JA, Zhang L, Walsh TR, Wiedemann B, Bennett PM, Avison MB. 2010. Induction of beta-lactamase production in Aeromonas hydrophila is responsive to betalactam-mediated changes in peptidoglycan composition. Microbiology 156:2327-2335.
12. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86. (Pubitemid 28269135)
13. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
14. Monteiro C, Fang X, Ahmad I, Gomelsky M, Romling U. 2011. Regulation of biofilm components in Salmonella enterica serovar Typhimurium by lytic transglycosylases involved in cell wall turnover. J. Bacteriol. 193:6443-6451.
15. Loh B, Grant C, Hancock RE. 1984. Use of the fluorescent probe 1-Nphenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:546-551. (Pubitemid 14018094)
16. Lamers RP, Cavallari JF, Burrows LL. 2013. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAbetaN) permeabilizes the outer membrane of Gram-negative bacteria. PLoS One 8:e60666.
17. Giltner CL, Habash M, Burrows LL. 2010. Pseudomonas aeruginosa minor pilins are incorporated into type IV pili. J. Mol. Biol. 398:444-461.
18. Blackburn NT, Clarke AJ. 2002. Characterization of soluble and membrane-bound family 3 lytic transglycosylases from Pseudomonas aeruginosa. Biochemistry 41:1001-1013. (Pubitemid 34062003)
19. Legaree BA, Clarke AJ. 2008. Interaction of penicillin-binding protein 2 with soluble lytic transglycosylase B1 in Pseudomonas aeruginosa. J. Bacteriol. 190:6922-6926.
20. Nikolaidis I, Izore T, Job V, Thielens N, Breukink E, Dessen A. 2012. Calcium-dependent complex formation between PBP2 and lytic transglycosylase SltB1 of Pseudomonas aeruginosa. Microb. Drug Resist. 18:298-305.
21. Reid CW, Blackburn NT, Clarke AJ. 2006. Role of arginine residues in the active site of the membrane-bound lytic transglycosylase B from Pseudomonas aeruginosa. Biochemistry 45:2129-2138. (Pubitemid 43271313)
22. Reid CW, Legaree BA, Clarke AJ. 2007. Role of Ser216 in the mechanism of action of membrane-bound lytic transglycosylase B: further evidence for substrate-assisted catalysis. FEBS Lett. 581:4988-4992. (Pubitemid 47531774)
23. Alvarez-Ortega C, Wiegand I, Olivares J, Hancock RE, Martinez JL. 2010. Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob. Agents Chemother. 54: 4159-4167.
24. Juan C, Moya B, Perez JL, Oliver A. 2006. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring highlevel beta-lactam resistance involves three AmpD homologues. Antimicrob. Agents Chemother. 50:1780-1787.
25. Blackburn NT, Clarke AJ. 2001. Identification of four families of peptidoglycan lytic transglycosylases. J. Mol. Evol. 52:78-84. (Pubitemid 32127943)
26. Uehara T, Dinh T, Bernhardt TG. 2009. LytM-domain factors are required for daughter cell separation and rapid ampicillin-induced lysis in Escherichia coli. J. Bacteriol. 191:5094-5107.
27. Heidrich C, Ursinus A, Berger J, Schwarz H, Holtje JV. 2002. Effects of multiple deletions of murein hydrolases on viability, septum cleavage, and sensitivity to large toxic molecules in Escherichia coli. J. Bacteriol. 184: 6093-6099. (Pubitemid 35265888)
28. Tomasz A, Albino A, Zanati E. 1970. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 227:138-140.
29. Kohanski MA, Dwyer DJ, Collins JJ. 2010. How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8:423-435.
30. Kraft AR, Prabhu J, Ursinus A, Holtje JV. 1999. Interference with murein turnover has no effect on growth but reduces beta-lactamase induction in Escherichia coli. J. Bacteriol. 181:7192-7198.
31. Korsak D, Liebscher S, Vollmer W. 2005. Susceptibility to antibiotics and beta-lactamase induction in murein hydrolase mutants of Escherichia coli. Antimicrob. Agents Chemother. 49:1404-1409. (Pubitemid 40463369)
32. van Asselt EJ, Dijkstra AJ, Kalk KH, Takacs B, Keck W, Dijkstra BW. 1999. Crystal structure of Escherichia coli lytic transglycosylase Slt35 reveals a lysozyme-like catalytic domain with an EF-hand. Structure 7:1167-1180. (Pubitemid 29482979)
33. van Asselt EJ, Thunnissen AM, Dijkstra BW. 1999. High resolution crystal structures of the Escherichia coli lytic transglycosylase Slt70 and its complex with a peptidoglycan fragment. J. Mol. Biol. 291:877-898. (Pubitemid 29403618)
34. Artola-Recolons C, Carrasco-Lopez C, Llarrull LI, Kumarasiri M, Lastochkin E, Martinez de Ilarduya I, Meindl K, Uson I, Mobashery S, Hermoso JA. 2011. High-resolution crystal structure of MltE, an outer membrane-anchored endolytic peptidoglycan lytic transglycosylase from Escherichia coli. Biochemistry 50:2384-2386.
35. van Asselt EJ, Kalk KH, Dijkstra BW. 2000. Crystallographic studies of the interactions of Escherichia coli lytic transglycosylase Slt35 with peptidoglycan. Biochemistry 39:1924-1934. (Pubitemid 30123999)
36. Scheurwater E, Reid CW, Clarke AJ. 2008. Lytic transglycosylases: bacterial space-making autolysins. Int. J. Biochem. Cell Biol. 40:586-591. (Pubitemid 351288584)
37. Liao X, Hancock RE. 1997. Identification of a penicillin-binding protein 3 homolog, PBP3x, in Pseudomonas aeruginosa: gene cloning and growth phase-dependent expression. J. Bacteriol. 179:1490-1496. (Pubitemid 27100433)
38. van Heijenoort J. 2011. Peptidoglycan hydrolases of Escherichia coli. Microbiol. Mol. Biol. Rev. 75:636-663.
39. Legaree BA, Daniels K, Weadge JT, Cockburn D, Clarke AJ. 2007. Function of penicillin-binding protein 2 in viability and morphology of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 59:411-424. (Pubitemid 47073446)
40. Balasubramanian D, Schneper L, Merighi M, Smith R, Narasimhan G, Lory S, Mathee K. 2012. The regulatory repertoire of Pseudomonas aeruginosa AmpC ss-lactamase regulator AmpR includes virulence genes. PLoS One 7:e34067.
41. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, Ernst S, Will O, Kaul R, Raymond C, Levy R, Chun-Rong L, Guenthner D, Bovee D, Olson MV, Manoil C. 2003. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 100:14339-14344. (Pubitemid 37499238)
42. Asikyan ML, Kus JV, Burrows LL. 2008. Novel proteins that modulate type IV pilus retraction dynamics in Pseudomonas aeruginosa. J. Bacteriol. 190:7022-7034.